Stage IIIB Primary Peritoneal Cancer: Clinical Trials

2 completed. 2 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	2	Completed 2

Follow Stage IIIB Primary Peritoneal Cancer: new trials by email Literature Review of Stage IIIB Primary Peritoneal Cancer trials Research Report on Stage IIIB Primary Peritoneal Cancer

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer Carboplatin, Glutathione, Laboratory Biomarker Analysis - Chemotherapeutic Agent Toxicity, Neuropathy	Phase 3	Completed	Alliance for Clinical Trials in Oncology	195	2009-12-01	2017-02-23
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Bevacizumab, Carboplatin, Laboratory Biomarker Analysis - Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma	Phase 3	Completed	National Cancer Institute (NCI)	1873	2005-09-01	2019-07-23

Narrower conditions

Fallopian Tube Neoplasms (2)  ·  Ovarian Neoplasms (2)  ·  Brenner Tumor (1)  ·  Neurotoxicity Syndromes (1)  ·  Pain (1)

Broader conditions

Adnexal Diseases (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Fallopian Tube Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Gonadal Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Ovarian Diseases (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)

Interventions

Carboplatin (2)  ·  Paclitaxel (2)  ·  Taxes (2)  ·  Bevacizumab (1)  ·  Disulfides (1)  ·  Glutathione (1)  ·  Immunoglobulin G (1)

Sponsors

Alliance for Clinical Trials in Oncology (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)  ·  Canada (1)  ·  Japan (1)  ·  South Korea (1)

Top investigators

Charles Loprinzi (1)  ·  Robert Burger (1)

Results publications

PMID 21941283, PMID 22204724, PMID 23219660, PMID 26487588, PMID 29550184, PMID 31216226, PMID 35144591, PMID 36252167, PMID 37185961

NIH funding

U10CA027469 (1), U10CA037404 (1), U10CA180868 (1)